Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck, Sanofi hope for sales expansion with two-dose Gardasil switch
Fierce Vaccines
Friday, April 18, 2014 - 11:47am
tags:
Gardasil, Merck, Sanofi, vaccines, HPV
Biotech VCs wager $1.1B in Q1, starting the year with a flurry of new deals
Fierce Biotech
Friday, April 18, 2014 - 11:43am
tags:
venture capital, biotech
Will Merck & Co. Inc Unseat Biotech's Hottest Drug?
Motley Fool
Friday, April 18, 2014 - 11:42am
tags:
Merck, MK-5172, MK-8742, Sovaldi, Gilead, hepatitis C
FDA wants stronger warning labels for long-acting opioids
Yahoo/Reuters
Friday, April 18, 2014 - 10:15am
tags:
FDA, warnings, opioids, Zohydro
India's Glenmark pulls 2,900 bottles of ulcer drug in U.S.
Yahoo/Reuters
Friday, April 18, 2014 - 10:12am
tags:
India, Glenmark, stomach ulcers, recalls, ranitidine
Potential New Treatment for Alcoholism: Ezogabine
Forbes
Friday, April 18, 2014 - 10:02am
tags:
alcoholism, GSK, Allezoe, Potiga
Cost of Treatment May Influence Doctors
NY Times, NY
Friday, April 18, 2014 - 9:30am
tags:
physicians, Sovaldi, Gilead Sciences
Earnings Primer: What's on Deck for Celgene, AbbVie, and Gilead
Motley Fool
Friday, April 18, 2014 - 9:00am
tags:
Celgene, Gilead Sciences, AbbVie, earnings
Impax to Sell Authorized Generic Renvela
Yahoo/Zacks.com
Friday, April 18, 2014 - 8:58am
tags:
Impax Labs, generics, Sanofi, Renvela, chronic kidney disease
The Law of Gravity Isn't Working for This Off-Patent Drug
Bloomberg Businessweek
Friday, April 18, 2014 - 8:52am
tags:
patents, Diovan, Novartis, generics, Ranbaxy
FDA Grants Fast Track Status To Amgen Heart Failure Drug
Forbes
Friday, April 18, 2014 - 8:51am
tags:
FDA, Amgen, fast track, ivabradine, heart failure
Johnson & Johnson's 3 Major Strengths
Motley Fool
Thursday, April 17, 2014 - 4:08pm
tags:
JNJ
FDA approves Ragwitek for short ragweed pollen allergies
FDA
Thursday, April 17, 2014 - 4:06pm
tags:
FDA, ragweed pollen allergy, Ragwitek, Merck
Zogenix Shares Soar on Massachusetts Developments
Yahoo/Zacks.com
Thursday, April 17, 2014 - 3:51pm
tags:
Zogenix, Zohydro ER, Massachusetts
2 Reasons Why Merck & Co. Is Crushing the Dow
Motley Fool
Thursday, April 17, 2014 - 12:21pm
tags:
Merck
Pharma Gets Social: Pinterest for Pharma, revisited
Pharmaforum
Thursday, April 17, 2014 - 12:17pm
tags:
social media, Pinterest
England agrees funding for Gilead hepatitis C drug
Yahoo/Reuters
Thursday, April 17, 2014 - 12:10pm
tags:
England, Gilead, hepatitis C, Sovaldi
FDA warns Endo Health on AMS pelvic mesh plant
Mass Device
Thursday, April 17, 2014 - 12:09pm
tags:
FDA, pelvic mesh, devices, Endo Health Solutions, American Medical Systems
AbbVie Candidate in Pivotal Study
Yahoo/Zacks.com
Thursday, April 17, 2014 - 11:51am
tags:
AbbVie, veliparib, non-small cell lung cancer
Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides
Motley Fool
Thursday, April 17, 2014 - 11:49am
tags:
Sovaldi, hepatitis C, Gilead Sciences, AbbVie, Merck, Bristol-Myers Squibb, Express Scripts

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.